Abstract:BACKGROUND: Bioartificial liver support systems are becoming an effective therapy for hepatic failure. Bioreactors, as key devices in these systems, can provide a favorable growth and metabolic environment, mass exchange, and immunological isolation as a platform. Currently, stagnancy in bioreactor research is the main factor restricting the development of bioartificial liver support systems. DATA SOURCES: A PubMed database search of English-language literature was performed to identify relevant articles using the keywords "bioreactor", "bioartificial liver", "hepatocyte", and "liver failure". More than 40 articles related to the bioreactors of bioartificial livers were reviewed. RESULTS: Some progress has been made in the improvement of structures, functions, and modified macromolecular materials related to bioreactors in recent years. The current data on the improvement of bioreactor configurations for bioartificial livers or on the potential of the use of certain scaffold materials in bioreactors, combined with the clinical efficacy and safety evaluation of cultured hepatocytes in vitro, indicate that the AMC (Academic Medical Center) BAL bioreactor and MELS (modular extracorporeal liver support) BAL bioreactor system can partly replace the synthetic and metabolic functions of the liver in phase I clinical studies. In addition, it has been indicated that the microfluidic PDMS (polydimethylsiloxane) bioreactor, or SlideBioreactor, and the microfabricated grooved bioreactor are appropriate for hepatocyte culture, which is also promising for bioartificial livers. Similarly, modified scaffolds can promote the adhesion, growth, and function of hepatocytes, and provide reliable materials for bioreactors. CONCLUSIONS: Bioreactors, as key devices in bioartificial livers, play an important role in the therapy for liver failure both now and in the future. Bioreactor configurations are indispensable for the development of bioartificial livers used for liver failure, just as the modified scaffold materials available for bioreactors are favorable to the construction of effective bioartificial livers.

Changes and perspectives of non-biological artificial liver treatment

Application of artificial liver support system in treatment of liver failure

[Current Status and Perspectives of Artificial Liver for Treatment of Acute-on-chronic Liver Failure].

[Research Advances in Diagnosis and Treatment of Liver Failure in 2016].

Bioartificial liver and liver transplantation: new modalities for the treatment of liver failure

Liver failure and the progress of Li's artificial liver system

Liver Transplantation in Patients with Liver Failure: Twenty Years of Experience from China

Key Challenges to the Development of Extracorporeal Bioartificial Liver Support Systems

Treatment Options for Portal Hypertension in the Era of Liver Transplantation

Cell therapy in end-stage liver disease: replace and remodel

Artificial Liver Support System in China: a Review over the Last 30 Years.

A Single-Center Experience of Non-Bioartificial Liver Support Systems among Chinese Patients with Liver Failure

Systematic evaluation of extracorporeal bioartificial liver support system for the treatment of liver failure

Advances in cell sources of hepatocytes for bioartificial liver.

Progress in bioreactors of bioartificial livers.

Clinical observation on the treatment of acute liver failure by combined non-biological artificial liver

Artificial liver support systems: what is new over the last decade?

Systematic Review: Extracorporeal Bio-Artificial Liver-Support System for Liver Failure

Comparitive study of middle and mixed artificial livers in treatment of hepatic failure

A Clinical Study on the Treatment of Severe Hepatitis by a Combined Artificial Liver.

The Development of a New Bioartificial Liver and Its Application in 12 Acute Liver Failure Patients